Express Scripts, which had its $26 billion buyout offer for Caremark Rx rejected, sent a letter to the company's shareholders and the Securities and Exchange Commission on Wednesday claiming that Caremark overstated savings from a proposed merger with drug store chain CVS. Caremark shareholders are due to meet Feb. 20 to consider the CVS deal.

Full Story:

Related Summaries